It’s time to take on your
enlarged prostate (BPH).

Learn about a non-surgical approach
through the Expander-2 Trial • Now enrolling

Millions of men struggle with urinary symptoms caused by an enlarged prostate, or BPH (benign prostatic hyperplasia). Nearly half of men in their 50’s and over 70% of men in their 60’s have BPH.1 As the prostate enlarges, it can cause a range of symptoms such as:

  • Frequent need to urinate both day and night
  • Weak or interrupted urinary stream
  • A sense that you cannot completely empty your bladder
  • Urgent feeling of needing to urinate

While there are medications and surgical treatments available for BPH, they do not work for everyone and can also cause unwanted side effects, including sexual dysfunction and urinary incontinence.

If you’re living with BPH and are interested in exploring non-surgical treatment options, you may qualify for the EXPANDER-2 Clinical Trial. The study is for the Urocross Expander System - an investigational, temporary implant designed to relieve BPH symptoms through a non-surgical procedure.

The Urocross™ Expander System

A temporary implant designed to relieve BPH symptoms

The prostate is about the size of a walnut, and is located at the neck of the bladder. For most men, starting around age 40 their prostate begins to grow. As the prostate enlarges it presses against the urethra, the tube that carries urine out of the body. This pressure blocks the natural flow of urine, causing uncomfortable symptoms and irritation.

The Urocross Implant is an investigational, temporary implant designed to relieve BPH symptoms through a non-surgical procedure called the PURE™ procedure (Prostatic Urethral REshaping). Urocross is a self-expanding implant that, once positioned, gently re-shapes and opens the narrowed urethra to improve urinary flow. The PURE procedure is performed using a flexible cystoscope and does not involve any incisions, allowing patients to return home the same day.

The Urocross Implant is left in place for 6 months to help re-shape the urethra, and is then removed through an outpatient procedure, leaving nothing behind.

What is the Expander-2 Trial?

The Urocross Expander System is currently being offered at select sites in the US and Canada through the Expander-2 Clinical Trial. If you qualify and decide to join the study, you will receive the Urocross procedure and all study-related care at no cost. You will also be compensated for your time and travel to attend periodic visits at your study doctor’s office to evaluate your progress.

See If You Qualify

To see if you might qualify for the Expander-2 Clinical Trial, and to get connected with your local study center to learn more, please take the pre-screening questionnaire below:

1. Berry, et al., Journal of Urology 1984